Aldeyra Therapeutics, Inc.
ALDX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001341235
No open-market purchases or sales by Aldeyra Therapeutics, Inc. insiders were filed in the last 90 days; 107 institutions reported holding it in 13F filings for Q2 2026, worth $77.7M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Aldeyra Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 115 | 1 | 111 | −3 |
| Shares | 36.5M | 340 | 38.6M | +2.13M (+5.8%) |
| Value | $146.7M | $1.00K | $171.8M | +$25.1M (+17.1%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Aldeyra Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tri Locum Partners LP | 1,447,445 | $6.43M | 2.51% |
| 683 Capital Management, LLC | 500,000 | $2.22M | 0.13% |
| Ikarian Capital, LLC | 375,000 | $1.67M | 0.51% |
| Woodstock Corp | 70,998 | $316.0K | 0.04% |
| Boothbay Fund Management, LLC | 53,212 | $237.0K | 0.01% |
| Nisa Investment Advisors, LLC | 50,600 | $225.0K | 0.00% |
| Prudential Financial Inc | 39,654 | $176.0K | 0.00% |
| Tobias Financial Advisors, Inc. | 34,173 | $152.0K | 0.05% |
| PDT Partners, LLC | 18,470 | $82.0K | 0.01% |
| Amalgamated Bank | 7,928 | $35.0K | 0.00% |
| Amalgamated Financial Corp. | 7,928 | $35.0K | 0.00% |
| Worth Asset Management, LLC | 500 | $1.00K | 0.00% |
| Central Trust Co | 17 | $0 | 0.00% |
| The PNC Financial Services Group, Inc. | 40 | $0 | 0.00% |
| CWM, LLC | 39 | $0 | 0.00% |
| Capital Advisors, Ltd. LLC | 3 | $0 | 0.00% |
| Tradewinds Capital Management, LLC | 35 | $0 | 0.00% |
| Ellevest, Inc. | 39 | $0 | 0.00% |
Sold out (21)
Institutions that held Aldeyra Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Acuta Capital Partners, LLC | 500,000 | $2.00M |
| DLD Asset Management, LP | 250,000 | $1.00M |
| Rafferty Asset Management, LLC | 212,975 | $852.0K |
| Stonepine Capital Management, LLC | 200,000 | $800.0K |
| Candriam Luxembourg S.C.A. | 140,000 | $560.0K |
| Caption Management, LLC | 138,600 | $555.0K |
| Ergoteles LLC | 114,795 | $459.0K |
| Affinity Asset Advisors, LLC | 100,759 | $403.0K |
| Engineers Gate Manager LP | 73,594 | $294.0K |
| Gyon Technologies Capital Management, LP | 51,161 | $205.0K |
| Mesirow Financial Investment Management, Inc. | 48,711 | $195.0K |
| Virtu Financial LLC | 32,401 | $130.0K |
| Alliancebernstein L.P. | 15,200 | $61.0K |
| ProShare Advisors LLC | 10,602 | $43.0K |
| Graham Capital Management, L.P. | 10,047 | $40.0K |
| Point72 Hong Kong Ltd | 7,702 | $31.0K |
| Cutler Group LP | 4,458 | $17.0K |
| Bank Julius Baer & Co. Ltd, Zurich | 3,500 | $14.0K |
| Eagle Bay Advisors LLC | 1,700 | $7.00K |
| Comprehensive Financial Consultants Institutional, Inc. | 800 | $3.00K |
| Truvestments Capital LLC | 419 | $2.00K |
Not filed for Q1 2022 yet (1)
Institutions that held Aldeyra Therapeutics, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| NEXT Financial Group, Inc | 340 | $1.00K |